Why parents may have a greater sense of appreciation for life
Parenthood doesn't guarantee happiness, but it can offer meaning and a sense of direction in life. (Rawpixel pic)
PARIS : Parenthood is frequently perceived as an essential step towards personal fulfilment. Behind this tenacious myth lies a more nuanced reality – having children doesn't necessarily make you happier, but it may well make life more meaningful, according to a major European study published in the Journal of Marriage and Family.
Conducted by Ansgar Hudde and Marita Jacob, researchers at the University of Cologne, this sociological survey is based on the responses of over 43,000 Europeans from 30 countries. The experts aimed to identify the effects of parenthood on the two pillars of well-being: life satisfaction, and the feeling of leading a meaningful life.
They found that being a parent doesn't systematically make people happier, especially over the long term. On the other hand, it does profoundly alter people's perception of their own existence.
'Previous debates about parenthood have focused too much on happiness and satisfaction,' Hudde explained. 'Our study shows that people who have children are not automatically happier, but they are more likely to feel that their own lives are meaningful and valuable.'
However, the relationship between parenthood and life satisfaction varies in relation to social circumstances. Mothers from modest backgrounds have a lower level of life satisfaction than women from equivalent socioeconomic backgrounds without children. On the other hand, this difference is much less pronounced among women from wealthier backgrounds.
As for men, the parental factor seems to carry little weight in life satisfaction, regardless of social background.
When it comes to finding meaning in life, however, boundaries blur. Whether men or women, rich or poor, parents are more likely to say their existence has value. This sense of meaning transcends borders and social circumstances.
And under certain conditions, happiness and meaning can go hand in hand. This is typically the case in Nordic countries, where family policies and institutional support enable parents to reconcile personal fulfilment and parenthood.
'The results show that good societal conditions can make both things possible: meaning and satisfaction,' Hudde stressed.
Among other major findings, the researchers reported that the birth of a first child triggers a peak in satisfaction – which is short-lived. On the other hand, the feeling of having a meaningful life takes hold for good.
It's a reminder that, while parenthood doesn't guarantee happiness, it can offer a sense of direction; a reason for being that can help us withstand the ups and downs of life.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
44 minutes ago
- Malay Mail
Game-changer or gimmick? What you need to know about the new weight-loss drugs sweeping the world
PARIS, June 22 — A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks. After France on Friday became the latest country to allow all doctors, rather than just specialists, to prescribe these drugs, here are some key questions about them. How do they work? The most well-known of this new wave of drugs are Danish pharma firm Novo Nordisk's Ozempic and Wegovy, as well as US company Eli Lilly's Mounjaro. These drugs enhance the action of a hormone in the pancreas called 'glucagon-like peptide 1', or GLP-1, the name given to this family of medications. The hormone affects the secretion of insulin, so was first targeted to develop drugs to combat diabetes. But it turned out that GLP-1 drugs also suppress people's appetite by making them feel fuller. Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. — Reuters pic A revolution? Obesity experts now agree that these drugs are a historic breakthrough in the history of people trying to lose weight. Previously, surgery was the main option for obesity when diet and exercise did not work. This is no small feat. Obesity affects 900 million people worldwide, in what is considered a major crisis. The new drugs 'cover a major unmet need: obesity was one of the only chronic diseases for which there were few medications,' French endocrinologist Emmanuel Disse told AFP. During clinical trials, the drugs have been found to reduce people's weight by an average of 15 to 20 per cent. Limitations? However these drugs do have some limitations, including side effects. The semaglutide drug used in Ozempic has been approved for diabetes since 2017, so there is now nearly a decade of research on its use. A large study using health data from hundreds of thousands of US veterans published in January found that GLP-1s are not linked to a higher risk of heart problems or suicidal thoughts, as had previously been suggested. However there are rare cases of serious side effects, such as damage to the pancreas, it said. More commonly, they can also cause nausea, vomiting, migraines and disturb sleep, which can turn some patients off the drugs. They also do not work for everyone – some people taking the drugs do not lose weight. And the effect only lasts when people are taking the drug, meaning that they potentially need lifelong treatment. They are also expensive, sometimes costing over US$1,000 a month in the United States to €300 in France. The drugs are also only available in injectable forms – though pharma firms are developing daily pills that have shown promise in early trials. Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen, Denmark, September 26, 2023. — Reuters pic Who should use them? National health agencies have emphasised that these drugs should only be prescribed to overweight or obese people for whom things like exercise and diet have failed. However there is plenty of evidence that some people who are not overweight use the drugs simply to lose a few extra kilos. France's ANSM medications authority said that these drugs should 'not be used for weight loss for aesthetic purposes,' warning that inappropriate use could expose people to 'adverse effects that are sometimes serious'. What next? Steven O'Rahilly, head of Cambridge University's Institute of Metabolic Sciences, told AFP he was confident there will be 'a pretty rapid evolution of drugs that are more effective, with fewer side effects, cheaper and more convenient'. 'It may be more of a challenge to combine all those four advances in a single medicine,' he added. With billions of dollars at stake, pharma firms are racing to be the first to market with a new treatment. Novo Nordisk's experimental drug amycretin could be even more effective than existing GLP-1s, according to early trial results published in The Lancet on Saturday. There has also been a growing field of research revealing the potential benefits of GLP-1 drugs beyond obesity. They have been linked to improvements for a range of maladies, including dementia and addiction. It is still unclear if these are a direct effect of the drugs, or are linked to improvements with obesity or diabetes. — AFP
Malay Mail
11 hours ago
- Malay Mail
French scientists find new blood type in Guadeloupe woman
BASSE-TERRE (Guadeloupe), June 21 — A French woman from the Caribbean island of Guadeloupe has been identified as the only known carrier of a new blood type, dubbed 'Gwada negative,' France's blood supply agency has announced. The announcement was made 15 years after researchers received a blood sample from a patient who was undergoing routine tests ahead of surgery, the French Blood Establishment (EFS) said yesterday. 'The EFS has just discovered the 48th blood group system in the world!' the agency said in a statement on social network LinkedIn. 'This discovery was officially recognised in early June in Milan by the International Society of Blood Transfusion (ISBT).' The scientific association had until now recognised 47 blood group systems. Thierry Peyrard, a medical biologist at the EFS involved in the discovery, told AFP that a 'very unusual' antibody was first found in the patient in 2011. However, resources at the time did not allow for further research, he added. Scientists were finally able to unravel the mystery in 2019 thanks to 'high-throughput DNA sequencing', which highlighted a genetic mutation, Peyrard said. The patient, who was 54 at the time and lived in Paris, was undergoing routine tests before surgery when the unknown antibody was detected, Peyrard said. This woman 'is undoubtedly the only known case in the world,' said the expert. 'She is the only person in the world who is compatible with herself,' he said. Peyrard said the woman inherited the blood type from her father and mother, who each had the mutated gene. The name 'Gwada negative', which refers to the patient's origins and 'sounds good in all languages', has been popular with the experts, said Peyrard. The ABO blood group system was first discovered in the early 1900s. Thanks to DNA sequencing the discovery of new blood groups has accelerated in recent years. Peyrard and colleagues are now hoping to find other people with the same blood group. 'Discovering new blood groups means offering patients with rare blood types a better level of care,' the EFS said. — AFP
Malay Mail
a day ago
- Malay Mail
Warming planet, wheezing people: How climate change is triggering an allergy crisis
PARIS, June 20 — Runny nose, itching eyes, worsening asthma symptoms — the effects of hay fever are nothing to sneeze at, experts say, warning of an 'explosion' of allergies as climate change lengthens and intensifies pollen seasons. The UN's World Meteorological Organisation (WMO) has found that a shifting climate has already begun altering the production and distribution of pollen and spores. As winter frost thaws earlier and spring weather gets warmer, plants and trees flower earlier, extending the pollen season, numerous studies have shown. Air pollution can also increase people's sensitivity to allergens, while invasive species are spreading into new regions and causing fresh waves of allergies. More and more people, particularly in industrialised nations, have reported developing allergy symptoms in recent decades. Around a quarter of adults in Europe suffer from airborne allergies, including severe asthma, while the proportion among children is 30 to 40 per cent. That figure is expected to rise to half of Europeans by 2050, according to the World Health Organisation. 'We're in crisis because allergies are exploding,' said Severine Fernandez, president of the French Allergists' Union. Whereas previously an allergic person would endure only what is commonly known as hay fever, albeit sometimes for years, 'now that person can become asthmatic after one or two years', Fernandez said. Climate change affects allergy patients in multiple ways, according to a 2023 report by the WMO. — Picture by Raymond Manuel 'Irritant pollen' Climate change affects allergy patients in multiple ways, according to a 2023 report by the WMO. Rising levels of carbon dioxide, one of the main heat-trapping gases produced by burning fossil fuels, boost plant growth, in turn increasing pollen production. Air pollution not only irritates the airways of people exposed, but it also causes stress to plants, which then produce more 'allergenic and irritant pollen'. Nicolas Visez, an aerobiologist at the University of Lille, said each plant species reacted differently to a variety of factors such as water availability, temperature and CO2 concentrations. Birch trees for example will wither as summers get hotter and drier, while the heat causes a proliferation of ragweed, a highly allergenic invasive plant. 'There's no doubt that climate change is having an effect,' Visez said. In a study published in 2017, researchers projected that ragweed allergies would more than double in Europe by 2041-2060 as a result of climate change, raising the number of people affected from 33 million to 77 million. The authors suggested that higher pollen concentrations as well as longer pollen seasons could make symptoms more severe. A bee feeds on the nectar and pollen of a scarlet powder-puff wildflower at Eaton Canyon in Pasadena, California June 3, 2023. A Europe-wide 'AutoPollen' programme under development aims to provide real-time data on the distribution of pollen and fungal spores. — AFP pic Allergy action A Europe-wide 'AutoPollen' programme under development aims to provide real-time data on the distribution of pollen and fungal spores. In Switzerland, a tie-up with MeteoSwiss allows patients and doctors to match personal allergy profiles with maps of specific allergens throughout the country. In parts of France, authorities have planted 'pollinariums', gardens packed with the main local allergen species. These provide information on the very first pollen released into the air so that people can start taking antihistamines and other protective measures in a timely manner. 'Hazelnuts have started to bloom as early as mid-December, which wasn't the case before,' said Salome Pasquet, a botanist with the association behind the pollen gardens. 'That's really because we've had very mild winters, so flowering has come earlier,' she said. Some countries are taking an interventionist approach — cutting off the pollen at the source. In Japan, the government announced a plan in 2023 to combat allergies caused by the archipelago's many cedar trees, which includes felling cedars to replace them with species that produce less pollen. Countries in Europe are also more mindful of species in the environment, both native ones that have been planted and invasive newcomers like ragweed. Preference is given to species with a lower allergenic potential, such as maple or fruit trees. 'The idea is not to stop planting allergenic species,' Pasquet said, but to be mindful of creating diversity and avoiding having 'places where there are rows of birch trees, as was the case a few years ago'. It was birch trees in a client's garden that originally set off symptoms for Simon Barthelemy, an architect who lives near Paris. 'I had a major eye allergy, and it's been a recurring problem every year since,' he said. 'I'm on antihistamines, but if I don't take them I get itchy eyes, I'm very tired, I cough... I can't sleep at night.' — AFP
